Product Information
ZITUVIMET 50-1,000 MG TABLET is a brand product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $5.0308 per EA under NDC 70710178706. Its NADAC has been published 62 times since Apr 23, 2025.
Strength
1000; 50 mg/1; mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710178706
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
METFORMIN HYDROCHLORIDE; SITAGLIPTINApproval Type
New Drug (NDA)
FDA Application
NDA216743On Market Since
3/14/2024
Pharmacological Classes
Price Statistics
The NADAC for ZITUVIMET 50-1,000 MG TABLET has been published 62 times since Apr 23, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.0308 per EA |
|---|---|
| All-time high | $5.0496 (May 14, 2025) |
| All-time low | $5.0308 (Apr 22, 2026) |
| 52-week high | $5.0469 |
| 52-week low | $5.0308 |
| Median price | $5.0378 |
| Average price | $5.0385 |
| Largest weekly change | +0.2% (Jul 23, 2025) |
| Weeks tracked | 62 |
| Tracking since | Apr 23, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Sitagliptin and Metformin Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ZITUVIMET 50-1,000 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ZITUVIMET 50-1,000 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $5.0308 per EA (NDC 70710178706), effective Jun 24, 2026.
How has the price of ZITUVIMET 50-1,000 MG TABLET changed over time?
Over the history we have for it, the NADAC for ZITUVIMET 50-1,000 MG TABLET has held within roughly two percent of its current level. It has been tracked across 62 weekly CMS publications since Apr 23, 2025.
What are the highest and lowest recorded NADAC prices for ZITUVIMET 50-1,000 MG TABLET?
Since Apr 23, 2025, the NADAC for ZITUVIMET 50-1,000 MG TABLET has ranged from a low of $5.0308 (Apr 22, 2026) to a high of $5.0496 (May 14, 2025), with a median of $5.0378 per EA.
Are there cheaper alternatives to ZITUVIMET 50-1,000 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ZITUVIMET 50-1,000 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures ZITUVIMET 50-1,000 MG TABLET?
ZITUVIMET 50-1,000 MG TABLET (NDC 70710178706) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification